Geode Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.29B | Sell |
2,465,054
-4,531
| -0.2% | -$2.37M | 0.09% | 189 |
|
2025
Q1 | $1.56B | Buy |
2,469,585
+41,955
| +2% | +$26.5M | 0.12% | 141 |
|
2024
Q4 | $1.73B | Buy |
2,427,630
+155,369
| +7% | +$111M | 0.13% | 122 |
|
2024
Q3 | $2.38B | Sell |
2,272,261
-143,089
| -6% | -$150M | 0.19% | 89 |
|
2024
Q2 | $2.53B | Buy |
2,415,350
+38,759
| +2% | +$40.6M | 0.22% | 76 |
|
2024
Q1 | $2.28B | Buy |
2,376,591
+22,374
| +1% | +$21.5M | 0.21% | 82 |
|
2023
Q4 | $2.06B | Buy |
2,354,217
+34,231
| +1% | +$30M | 0.22% | 82 |
|
2023
Q3 | $1.91B | Buy |
2,319,986
+38,857
| +2% | +$31.9M | 0.23% | 79 |
|
2023
Q2 | $1.64B | Buy |
2,281,129
+63,136
| +3% | +$45.3M | 0.19% | 94 |
|
2023
Q1 | $1.82B | Buy |
2,217,993
+10,003
| +0.5% | +$8.2M | 0.24% | 80 |
|
2022
Q4 | $1.59B | Sell |
2,207,990
-32,123
| -1% | -$23.1M | 0.22% | 87 |
|
2022
Q3 | $1.54B | Buy |
2,240,113
+26,009
| +1% | +$17.9M | 0.23% | 76 |
|
2022
Q2 | $1.31B | Buy |
2,214,104
+121,333
| +6% | +$71.6M | 0.19% | 95 |
|
2022
Q1 | $1.46B | Buy |
2,092,771
+115,469
| +6% | +$80.5M | 0.18% | 98 |
|
2021
Q4 | $1.25B | Buy |
1,977,302
+237,090
| +14% | +$149M | 0.15% | 115 |
|
2021
Q3 | $1.05B | Buy |
1,740,212
+32,212
| +2% | +$19.4M | 0.14% | 124 |
|
2021
Q2 | $951M | Buy |
1,708,000
+97,810
| +6% | +$54.5M | 0.13% | 131 |
|
2021
Q1 | $760M | Buy |
1,610,190
+23,271
| +1% | +$11M | 0.12% | 151 |
|
2020
Q4 | $765M | Sell |
1,586,919
-170,067
| -10% | -$81.9M | 0.13% | 136 |
|
2020
Q3 | $982M | Buy |
1,756,986
+235,853
| +16% | +$132M | 0.19% | 96 |
|
2020
Q2 | $947M | Buy |
1,521,133
+188,616
| +14% | +$117M | 0.2% | 92 |
|
2020
Q1 | $649M | Buy |
1,332,517
+65,789
| +5% | +$32.1M | 0.17% | 121 |
|
2019
Q4 | $475M | Buy |
1,266,728
+25,165
| +2% | +$9.43M | 0.1% | 200 |
|
2019
Q3 | $344M | Buy |
1,241,563
+81,002
| +7% | +$22.4M | 0.08% | 253 |
|
2019
Q2 | $363M | Buy |
1,160,561
+62,713
| +6% | +$19.6M | 0.09% | 231 |
|
2019
Q1 | $450M | Buy |
1,097,848
+19,395
| +2% | +$7.95M | 0.12% | 179 |
|
2018
Q4 | $402M | Buy |
1,078,453
+78,143
| +8% | +$29.1M | 0.12% | 161 |
|
2018
Q3 | $403M | Buy |
1,000,310
+29,493
| +3% | +$11.9M | 0.11% | 169 |
|
2018
Q2 | $334M | Buy |
970,817
+34,841
| +4% | +$12M | 0.1% | 193 |
|
2018
Q1 | $322M | Buy |
935,976
+55,495
| +6% | +$19.1M | 0.1% | 193 |
|
2017
Q4 | $330M | Buy |
880,481
+30,581
| +4% | +$11.5M | 0.11% | 183 |
|
2017
Q3 | $379M | Buy |
849,900
+20,395
| +2% | +$9.1M | 0.14% | 138 |
|
2017
Q2 | $407M | Buy |
829,505
+97,071
| +13% | +$47.6M | 0.16% | 122 |
|
2017
Q1 | $283M | Buy |
732,434
+62,796
| +9% | +$24.3M | 0.12% | 178 |
|
2016
Q4 | $246M | Buy |
669,638
+31,097
| +5% | +$11.4M | 0.11% | 176 |
|
2016
Q3 | $256M | Buy |
638,541
+1,979
| +0.3% | +$794K | 0.13% | 155 |
|
2016
Q2 | $222M | Sell |
636,562
-4,248
| -0.7% | -$1.48M | 0.12% | 167 |
|
2016
Q1 | $231K | Buy |
640,810
+14,289
| +2% | +$5.14K | 0.12% | 156 |
|
2015
Q4 | $339M | Buy |
626,521
+5,085
| +0.8% | +$2.75M | 0.19% | 104 |
|
2015
Q3 | $288M | Buy |
621,436
+20,244
| +3% | +$9.4M | 0.18% | 114 |
|
2015
Q2 | $306M | Buy |
601,192
+18,970
| +3% | +$9.66M | 0.17% | 115 |
|
2015
Q1 | $262M | Buy |
582,222
+19,294
| +3% | +$8.7M | 0.15% | 134 |
|
2014
Q4 | $231M | Buy |
562,928
+24,929
| +5% | +$10.2M | 0.14% | 149 |
|
2014
Q3 | $194M | Sell |
537,999
-41,519
| -7% | -$14.9M | 0.13% | 161 |
|
2014
Q2 | $164M | Buy |
579,518
+3,446
| +0.6% | +$973K | 0.11% | 195 |
|
2014
Q1 | $173M | Buy |
576,072
+4,195
| +0.7% | +$1.26M | 0.12% | 179 |
|
2013
Q4 | $157M | Buy |
571,877
+21,813
| +4% | +$6M | 0.11% | 189 |
|
2013
Q3 | $172M | Buy |
550,064
+30,553
| +6% | +$9.56M | 0.14% | 147 |
|
2013
Q2 | $117M | Buy |
+519,511
| New | +$117M | 0.1% | 204 |
|